Shervin Gholizadeh Moghaddam Genentech Inc., Code E (Employment);
Jeffrey Bennett Mallinckrodt, Novartis, and the National Institutes of Health, Code F (Financial Support), Aquaporumab, Code P (Patent), Chugai Pharmaceutical,Viela Bio, Mitsubishi-Tanabe, Reistone Bio, Abbvie, Clene Neuroscience, Alexion, Genentech, and Roche, Code R (Recipient);
Edward Fox AbbVie, Biogen, Celgene, Chugai, EMD Serono, Genentech/Roche, MedDay , Novartis, Sanofi Genzyme, and TG, Code C (Consultant/Contractor), AbbVie, Biogen, Celgene, Chugai, EMD Serono, Genentech/Roche, MedDay , Novartis, Sanofi Genzyme, and TG, Code R (Recipient);
Benjamin Greenberg Alexion, Novartis, EMD Serono, Viela Bio, Genentech/Roche, Greenwich Biosciences, Axon Advisors, Rubin Anders, ABCAM, Signant, IQVIA, Sandoz, Druggability Technologies, Genzyme, and Immunovant, Code C (Consultant/Contractor), Clene Nanomedicine, Code F (Financial Support), UpToDate, Code R (Recipient);
Brian Weinshenker UCB Biosciences, Mitsubishi Tanabe, Genentech, and Roche, Code C (Consultant/Contractor), NMO-IgG for diagnosis of neuromyelitis optica, Code P (Patent), Genentech, Roche, and Novartis, Code R (Recipient), Chugai, Code R (Recipient), RSR Ltd., Oxford University, Hospices Civils de Lyon, and MVZ Labor PD Dr. Volkmann und Kollegen GbR, Code R (Recipient), Attack Adjudication Committee for Alexion and Horizon Therapeutics (formerly MedImmune/Viela Bio), Code S (non-remunerative);
Anthony Traboulsee Genzyme, Roche, and Novartis , Code C (Consultant/Contractor), Genzyme and Roche, Code R (Recipient);
Michael Yeaman Roche and Alexion, Code C (Consultant/Contractor), NIH and DoD, Code F (Financial Support), NovaDigm Therapeutics, Inc. and Metacin, Inc, Code O (Owner), Genentech-Roche Strategic Scientific Committee for NMOSD, Chair Medical Advisor to the Guthy-Jackson Charitable Foundation for NMO, Code S (non-remunerative);
Kathleen Blondeau F. Hoffmann-La Roche Ltd., Code E (Employment);
Kristina Weber F. Hoffmann-La Roche Ltd., Code E (Employment);
Ivana Vodopivec F. Hoffmann-La Roche Ltd., Code E (Employment);
Michael Levy Alexion, Viela Bio, Genentech/Roche, UCB Pharmaceuticals, Mitsubishi Pharmaceuticals and Sanofi, Code C (Consultant/Contractor), NIH, Alexion, Bluerock, Siegel Rare Neuroimmune Association, Sumaira Foundation, and Genentech, Code F (Financial Support)